网站主页>>>项目整合>>>其它产品项目整合
项目整合的本质是一项集合成方法学、反应工程学与过程分析技术于一体的系统工程。其核心逻辑可以概括为以下几点:源头优选:利用如N-硝胺化学等底层方法学突破,从分子层面颠覆传统高成本、高污染路线。过程强化:依托连续流技术,攻克有机金属试剂应用、光化学反应放大等“不可能”任务,实现高危工艺的本质安全。系统集成:整合“反应-淬灭-分离”全流程,利用微流控与在线分析技术,消除批次间的差异,实现药品制造的连续化与智能化。当前,中间体工艺研发正在经历从“经验驱动”向“数据驱动”的转变。AI辅助路线设计、自动化高通量筛选与连续制造平台的结合,将使得“分子结构与最优工艺路径”之间的映射关系逐渐清晰。未来的竞争优势,将属于那些能够将底层化学创新与先进工程技术进行无缝整合的研发体系。
备注: 根据相关法律法规, 本站点不显示有法律约束管制的产品, 如有遗漏, 请自行鉴别,或提交我们及时更新撤除.
如有产品相关项目调研推广服务, 请致函联系我们

客户展示

示例图片

其它产品项目整合

  • Tripelennamine CAS Registry Number: 91-81-6 曲吡那敏


    CAS Name: N,N-Dimethyl-N'-(phenylmethyl)-N'-2-pyridinyl-1,2-ethanediamine
    Additional Names: 2-[benzyl(2-dimethylaminoethyl)amino]pyridine; N-benzyl-N',N'-dimethyl-N-(2-pyridyl)ethylenediamine; ...
    Literature References: Prepn: C. P. Huttrer et al., J. Am. Chem. Soc. 68, 1999 (1946); C. Djerassi et al., US 2406594 (1946 to Ciba); R. J. Horclois, US 2502151 (1950 to Rhône-Poulenc). Crystal structure: M. Parvez, Acta Crystallogr. C43, 1408 (1987). Toxicity studies: D. P. Waller et al., Clin. Toxicol. 16, 17 (1980). Comprehensive description: H. G. Piskorik, Anal. Profiles Drug Subs. 14, 108-133 (1985).

  • Dimethoxane CAS Registry Number: 828-00-2 2,6-二甲基-1,3-二恶烷-4-醇乙酸酯


    CAS Name: 2,6-Dimethyl-1,3-dioxan-4-ol acetate
    Additional Names: 6-acetoxy-2,4-dimethyl-m-dioxane; 2,6-dimethyl-m-dioxan-4-yl acetate; acetomethoxane
    Trademarks: Dioxin (obsolete); Giv-Gard ...
    Literature References: Prepn: C. S. Marvel et al., J. Org. Chem. 4, 252 (1939); Späth et al., Ber. 76, 57 (1943). Description: Am. Perfum. Cosmet. 77, no. 12, 32-34 (1962), C.A. 58, 8848c (1963).

  • Propiverine CAS Registry Number: 60569-19-9 丙哌维林


    CAS Name: a-Phenyl-a-propoxybenzeneacetic acid 1-methyl-4-piperidinyl ester
    Additional Names: a,a-diphenyl-a-propoxyacetic acid 1-methyl-4-piperidyl ester; 1-methyl-4-piperidyl diphenylpropoxya...
    Literature References: Prepn: C. Starke et al., DD 106643 (1974), C.A. 82, 155841s (1975). GC-MS determn in plasma and urine: T. Marunaka et al., J. Chromatogr. 420, 43 (1987). Pharmacology: A. Haruno, Arzneim.-Forsch. 42, 815, 1459 (1992). Acute toxicity: K. Yamashita et al., J. Toxicol. Sci. 14, Suppl. 2, 1 (1989), C.A. 112, 172060 (1990). Clinical pharmacokinetics: C. Müller et al., Eur. J. Drug Metab. Pharmacokinet. 18, 265 (1993). Clinical trial in urinary incontinence: D. Mazur et al., Urologe A33, 447 (1994).

  • Bendroflumethiazide CAS Registry Number: 73-48-3 苄氟噻嗪


    CAS Name: 3,4-Dihydro-3-(phenylmethyl)-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
    Additional Names: 3-benzyl-6-trifluoromethyl-3,4-dihydro-7-sulfamoyl-2H-1,2,4-benz...
    Literature References: Prepn: C. T. Holdrege et al., J. Am. Chem. Soc. 81, 4807 (1959); F. Lund, W. O. Godtfredsen, GB 863474; eidem, US 3392168 (1961, 1968 both to Lövens Kemiske Fabrik). Comprehensive description: K. Florey, F. M. Russo-Alesi, Anal. Profiles Drug Subs. 5, 1-19 (1976).

  • Sulfarsphenamine CAS Registry Number: 618-82-6 硫胂凡纳明


    CAS Name: [1,2-Diarsenediylbis[(6-hydroxy-3,1-phenylene)imino]]bismethanesulfonic acid disodium salt
    Additional Names: disodium 3,3'-diamino-4,4'-dihydroxyarsenobenzene N-dimethylenesulfonate; ...
    Literature References: Prepn: C. Voegtlin, J. M. Johnson, J. Am. Chem. Soc. 44, 2573 (1922); W. J. C. Dyke, H. King, J. Chem. Soc. 1935, 1745.

  • Sulfamethazine CAS Registry Number: 57-68-1 磺胺二甲嘧啶


    CAS Name: 4-Amino-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide
    Additional Names: N1-(4,6-dimethyl-2-pyrimidinyl)sulfanilamide; N1-(4,6-dimethyl-2-pyrimidyl)sulfanilamide; 4,6-dimethyl-2-sul...
    Literature References: Prepn: Caldwell et al., J. Am. Chem. Soc. 63, 2188 (1941); Roblin et al., ibid. 64, 567 (1942); Weisner, Katscher, GB 546158 (1942 to Ward, Blenkinsop); Sprague, US 2407966 (1946 to Sharp Dohme). Alternate prepn: Haworth, Rose, GB 552887 (1943 to I.C.I.); Garzia, US 3119818 (1964 to Ist. Chemioterap. Ital.). Anticoccidiosis activity: Zarin, Feodorova, C.A. 66, 114, 435p-436q (1967). Metabolic studies: Turco et al., Clin. Pharmacol. Ther. 7, 603 (1966); Parker et al., Hum. Hered. 19, 402 (1969). Solubility studies: Shkadova et al., Farm. Zh. (Kiev) 24, 39 (1969). Acute toxicity: B. Bobranski et al., Arch. Immunol. Ther. Exp. 16, 804 (1968). Comprehensive description: C. Papostephanou, M. Frantz, Anal. Profiles Drug Subs. 7, 401-422 (1978).

  • Prolonium Iodide CAS Registry Number: 123-47-7 普鲁碘胺


    CAS Name: 2-Hydroxy-N,N,N,N',N',N'-hexamethyl-1,3-propanediaminium diiodide
    Additional Names: (2-hydroxytrimethylene)bis[trimethylammonium] iodide; 1,3-bis(trimethylamino)-2-propanol diiodide; ...
    Literature References: Prepn: Callsen, US 1526627 (1925).

  • Formocortal CAS Registry Number: 2825-60-7 福莫可他


    CAS Name: (11b,16a)-21-(Acetyloxy)-3-(2-chloroethoxy)-9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-20-oxopregna-3,5-diene-6-carboxaldehyde
    Additional Names: 3-(2-chloroethoxy)-9-flu...
    Literature References: Prepn: Camerino et al., FR 1396602 C.A. 63, 5713c (1965); NL 6508458; US 3314945 (1965, 1966, 1967 all to Farmitalia); Baldratti et al., Experientia 22, 468 (1966). Pharmacology: Suchowsky, Baldratti, Proc. 2nd Int. Congr. Horm. Steroids 1966, L. Martini, F. Fraschini, M. Motta, Eds. (Excerpta Medica Found., Amsterdam, 1967) pp 536-540; Tajima, Otsu, Jpn. J. Pharmacol. 62, 115 (1966), C.A. 67, 72329v (1967); Baldratti et al., Arzneim.-Forsch. 21, 1533 (1971). Toxicity studies: Bertazzoli et al., J. Eur. Toxicol. 4, 88 (1971).

  • Oxabolone CAS Registry Number: 4721-69-1 4-羟基诺龙


    CAS Name: (17b)-4,17-Dihydroxyestr-4-en-3-one
    Additional Names: 4-hydroxy-19-nortestosterone; 19-norandrost-4-ene-4,17b-diol-3-one
    Percent Composition: C 74.45%, H 9.02%, O 16.53%
    Literature References: Prepn: Camerino et al., US 2999870 and US 3145201 (1961, 1964, both to Farmitalia). Prepn of the cypionate: Camerino, Patelli, GB 879622 and US 3020295 (1961, 1962, both to Farmitalia).

  • Clostebol CAS Registry Number: 1093-58-9 氯司替勃


    CAS Name: (17b)-4-Chloro-17-hydroxyandrost-4-en-3-one
    Additional Names: 4-chlorotestosterone
    Percent Composition: C 70.68%, H 8.43%, Cl 10.98%, O 9.91%
    Literature References: Prepn: Camerino et al., Farmaco Ed. Sci. 11, 586 (1956); eidem, J. Am. Chem. Soc. 78, 3540 (1956); Ringold et al., J. Org. Chem. 21, 1432 (1956); Camerino, US 2953582 (1960 to Farmitalia); Julian, Printy, US 2933510 (1960 to Julian Labs.). Clinical pharmacology of the acetate: Molinatti et al., Folia Endocrinol. 14, 528 (1961); Krueskemper, Morgner, Int. Z. Klin. Pharmakol. Ther. Toxikol. 1, 455 (1968).

  • 免费注册, 助力研发,生产, 销售.

    招募中心

    我们的宗旨: 净化, 简洁, 高效Purifying, concise, efficient !我们的口号: 减少中间商赚差价!

    即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.

    试运营阶段,所有广告业务5折优惠

    分类广告投放

    依据化学成分的不同, 针对不同的企业和产品, 我们提供分类产品广告投放.

    客户展示

    示例图片
    优秀企业推荐
    ×

    通知